|
Infliximab Clinical Trials
8 actively recruiting trials across 7 locations
▲ +1 trial since August 2026
Also known as: Avakine, Avsola, Inflectra, Remicade, Remicaide +3 more
Pipeline
Phase 1: 1Phase 2: 4Phase 3: 1Phase 1/2: 1
Top Sponsors
- University of Nebraska1
- University of California, San Francisco1
- Swiss Dermatology Network for Targeted Therapies1
- Naresh Bumma1
- NYU Langone Health1
Indications
- Cancer5
- Arthritis3
- Lung Cancer2
- Locally Advanced Non-Small Cell Lung Cancer (NSCLC)1
- Rheumatic Disease1
Other1 trial
San Francisco, California1 trial
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
UCSF Medical Center
Phase 1/2
Athens, Georgia1 trial
Phase 2
Boston, Massachusetts1 trial
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Massachusetts General Hospital
Phase 2
Omaha, Nebraska1 trial
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
University of Nebraska Medical Center
Phase 3
New York, New York1 trial
Columbus, Ohio1 trial
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Ohio State University Comprehensive Cancer Center
Phase 2
Houston, Texas1 trial
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
M D Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.